Awarded contract

Enzyme Replacement Therapy Medicines

Details

Buyer: NHS National Services Scotland
Supplier(s): AVENTIS PHARMA LIMITED
Value: GBP 12,437,853
Topic: Pharmaceutical products
Published: 15 August 2024
Source: uk:public_contracts_scotland

Tender description

Supply of Enzyme Replacement Therapy Medicines (a-d) to NHS Scotland: - NP92624(a) Laronidase 500units/5ml solution for infusion vials 1 vial (Aldurazyme®) - NP92624(b) Imiglucerase 400unit powder for solution for infusion vials 1 vial (Cerezyme®) - NP92624(c) Agalsidase beta 35mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(c) Agalsidase beta 5mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(d) Alglucosidase alfa 50mg powder for solution for infusion vials 1 vial (Myozyme®) Lot 1: The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (a-d: Aldurazyme®/ Cerezyme®/ Fabrazyme®/ Fabrazyme®/ Myozyme®) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.

Timeline

Completed: Award date18 July 2024
Completed: Award published15 August 2024
Current notice

About the buyer

NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov